MedTrace Logo

Prospective Evaluation of Safety and Efficacy Vertebral Drug-eluting Stent System

NCT02328781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2020-06-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of Firehorus vertebral artery rapamycin-target-eluting stent system (hereinafter referred to as Firehorus) in treatment of symptomatic vertebral artery stenosis.

Conditions

  • Vertebrobasilar Insufficiency

Interventions

DEVICE

Drug-eluting stent

Sponsors & Collaborators

  • Zhongrong Miao

    lead OTHER

Principal Investigators

  • Zhongrong Miao, PhD,MD · Beijing Tiantan Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-17
Primary Completion
2016-06-14
Completion
2016-11-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02328781 on ClinicalTrials.gov